Mechanisms underlying the modulatory action of platelet activating factor (PAF) on the upregulation of kinin B 1 receptors in the rat paw

British Journal of Pharmacology

Volumn 139, Issue 5, 2003, Pages 973-981

  Fernandes, Elizabeth S ^a   Passos, Giselle F ^a   Campos, Maria M ^a   Araújo, José G V C ^b   Pesquero, Jorge L ^b   Avelllar, Maria C ^c   Teixeira, Mauro M ^b   Calixto, João B ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

B 1 receptor expression; Myeloperoxidase activity; Neutrophil influx; NF B binding activation; Oedema formation; Platelet activating factor

Indexed keywords

ACETYLLYSYLBRADYKININ[7 [3 (2 NAPHTHYL)ALANINE] 8 ISOLEUCINE 9 DEARGININE]; APAFANT; BRADYKININ B1 RECEPTOR; BRADYKININ B1 RECEPTOR ANTAGONIST; BRADYKININ DERIVATIVE; BRADYKININ[1-8]; BRADYKININ[8 LEUCINE 9 DEARGININE]; BRADYKININ[8 TYROSINE]; CYCLOHEXIMIDE; DEXAMETHASONE; FUCOIDIN; GRANULOCYTE ANTIBODY; KININ; MESSENGER RNA; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD18; PROTEIN SYNTHESIS INHIBITOR; PYRROLIDINE DITHIOCARBAMATE; RECEPTOR BLOCKING AGENT; RECEPTOR PROTEIN; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; TOSYLLYSYL CHLOROMETHYL KETONE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; DRUG MECHANISM; GENE EXPRESSION; MALE; NONHUMAN; PAW EDEMA; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; RAT STRAIN; RECEPTOR DOWN REGULATION; RECEPTOR INTRINSIC ACTIVITY; RECEPTOR UPREGULATION;

ANIMALS; EDEMA; FORELIMB; MALE; NEUTROPHILS; PLATELET ACTIVATING FACTOR; RATS; RATS, WISTAR; RECEPTOR, BRADYKININ B1; RNA, MESSENGER; UP-REGULATION;

EID: 0037961231     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705314     Document Type: Article

References (44)

1. ADAMS, J.K. & TEPPERMAN, B.L. (2001). Colonic production and expression of IL-4, IL-6, and IL-10 in neonatal suckling rats after LPS challenge. Am. J. Physiol. Gastrointest. Liver Physiol., 280, G755-G762.
2. 1 receptors in the polymorphonuclear leukocyte accumulation induced by IL-1β in vivo in the mouse. J. Immunol., 156, 269-274.
3. BHOOLA, K.D., FIGUEROA, C.D. & WORTHY, K. (1992). Bioregulation of kinins: kallikreins, kininogens and kininases. Pharmacol. Rev., 44, 1-80.
4. BÖCKMANN, S. & PAEGELOW, I. (2000). Kinins and kinin receptors: importance for the activation of leukocytes. J. Leukoc. Biol., 68, 587-592.
5. CABRINI, D.A., CAMPOS, M.M., TRATSK, K.S., MERINO, V.F., SILVA JR, J.A., SOUZA, G.E., AVELLAR, M.C., PESQUERO, J.B. & CALIXTO, J.B. (2001). Molecular and pharmacological evidence for modulation of kinin B(1) receptor expression by endogenous glucocorticoids hormones in rats. Br. J. Pharmacol., 132, 567-577.
6. CALIXTO, J.B., CABRINI, D.A., FERREIRA, J. & CAMPOS, M.M. (2000). Kinins in pain and inflammation. Pain, 87, 1-5.
7. CALIXTO, J.B., CABRINI, D.A., FERREIRA, J. & CAMPOS, M.M. (2001). Inflammatory pain: kinins and antagonists. Curr. Opin. Anaesthesiol., 14, 519-526.
8. 2 receptors in streptozotocin-diabetic rats. Eur. J. Pharmacol., 416, 169-177.
9. 2 receptors in bradykinin-induced rat paw oedema. Br. J. Pharmacol., 114, 1005-1013.
10. 2 receptors in oedema formation after long-term treatment with Mycobacterium bovis bacillus Calmette-Guérin (BCG). Br. J. Pharmacol., 120, 502-508.
11. 9-BK-induced rat paw oedema by systemic treatment with bacterial endotoxin. Br. J. Pharmacol., 117, 793-798.
12. 1 receptor-mediated rat paw oedema by IL-1β and TNFα. Peptides, 19, 1269-1276.
13. 1 kinin-receptor up-regulation. Evidence for involvement of protein kinases and nuclear factor-κB pathways.. Br. J. Pharmacol., 127, 1851-1859.
14. 1 receptors in rats. Br. J. Pharmacol., 135, 1107-1114.
15. CHAO, W. & OLSON, M.S. (1993). Platelet-activating factor: receptors and signal transduction. Biochem. J., 292, 617-629.
16. CHOI, J.H., CHUNG, W.J., HAN, S.J., LEE, H.B., CHOI, I.W., LEE , H.K., JANG, K.Y., LEE, D.G., HAN, S.S., PARK, K.H. & IM, S.Y. (2000). Selective involvement of reactive oxygen intermediates in platelet-activating factor-mediated activation of NF-kappaB. Inflammation, 24, 385-398.
17. CORDEIRO, R.S., MARTINS, M.A., SILVA, P.M., FARIA NETO, H.C., CASTANHEIRA, J.R. & VARGAFTIG, B.B. (1986). Desensitization to PAF-induced rat paw oedema by repeated intraplantar injections. Ltfe Sci., 39, 1871-1878.
18. COUTURE, R., HARRISSON, M., VIANNA, R.M. & CLOUTIER, F. (2001). Kinin receptors in pain and inflammation. Eur. J. Pharmacol., 429, 161-176.
19. D'ACQUISTO, F., ALENTI, A., IANARO, A. & CARNUCCIO, R. (1999). Nuclear factor-kappaB activation mediates inducible nitric oxide synthase expression in carrageenin-induced rat pleurisy. Naunyn Schmiedebergs Arch. Pharmacol., 360, 670-675.
20. DE PLAEN, I.G., TAN, X.D., CHANG, H., QU, X.W., LIU, Q.P. & HSUEH, W. (1998). Intestinal NF-κB is activated, mainly as p50 homodimers, by platelet-activating factor. Biochim. Biophys. Acta, 1392, 185-192.
21. DE PLAEN, I.G., TAN, X.D., CHANG, H., WANG, L., REMICK, D.G. & HSUEH, W. (2000). Lipopolysaccharide activates nuclear factor kappaB in rat intestine: role of endogenous platelet-activating factor and tumor necrosis factor. Br. J. Pharmacol., 129, 307-314.
22. EVANGELOU, A.M. (1994). Platelet-activating factor (PAF): implications for coronary heart and vascular diseases. Prostaglandins Leukot. Essent. Fatty Acids, 50, 1-28.
23. FRANCIOSE, R.J., MOORE, F.A., READ, R.A., CARL, V.S. & BANERJEE, A. (1996). Hypoxia/reoxygenation of human endothelium activates PMNs to detach endothelial cells via a PAF mechanism. J. Surg. Res., 61, 459-462.
24. HAN, S.J., KO, H.M., CHOI, J.H., SEO, K.H., LEE, H.S., CHOI, E.K., CHOI, I.W., LEE, H.K. & IM , S.Y. (2002). Molecular mechanisms for lipopolysaccharide-induced biphasic activation of nuclear factor-kappa B (NF-kappa B). J. Biol. Chem., 277, 44715-44721.
25. ISHII, I., SAITO, E., TAKASHI, I., UI, M. & SHIMIZU, T. (1998). Agonist-induced sequestration, recycling and resensitization of platelet-activating factor: role of citoplasmic tail phosphorylation in each process. J. Biol. Chem., 273, 9878-9885.
26. ISHII, S. & SHIMIZU, T. (2000). Platelet-activating factor (PAF) receptor and genetically engineered PAF receptor mutant mice. Prog. Lip. Res., 39, 41-82.
27. KO, H.M., SEO, K.H., HAN, S.J., AHN, K.Y., CHOI, I.H., KOH, G.Y., LEE, H.K., RA, M.S. & IM, S.Y. (2002). Nuclear factor kappaB dependency of platelet-activating factor-induced angiogenesis. Cancer Res., 62, 1809-1814.
28. KORTH, R.M., HIRAFUJI, M., BEVENISTE, J. & RUSSO-MARIE, F. (1995). Human umbilical vein endothelial cells: specific binding of platelet-activating factor and cytosolic calcium flux. Biochem. Pharmacol., 49, 1793-1799.
29. 1 kinin receptors induced by tissue injury. J. Immunol., 160, 1419-1426.
30. 1 receptors: a review. Immunopharmacology, 30, 1-26.
31. MARCEAU, F. & BACHVAROV, D.R. (1998). Kinin receptors. Clin. Rev. Allergy Inflamm., 16, 385-401.
32. 1 receptors for kinins. Pharmacol. Rev., 50, 357-386.
33. MCINTYRE, T.M., MODUR, V., PRESCOTT, S.M. & ZIMMERMANN, G.A. (1997). Molecular mechanisms of early inflammation. Thromb. Haem., 78, 302-305.
34. MCLEAN, P.G., AHLUWALIA, A. & PERRETTI, M. (2000). Association between kinin B1 receptor expression and leukocyte trafficking across mouse mesenteric 7postcapillary venules. J. Exp. Med., 192, 367-380.
35. NEWTON, R., EDDLESTON, J., HADDAD, E.B., HAWISA, S., MAK, J., LIM, S., FOX, A.J., DONELLY, L.E. & CHUNG, K.F. (2002). Regulation of kinin receptors in airway epithelial cells by inflammatory cytokines and dexamethasone. Eur. J. Pharmacol., 441, 193-202.
36. PINHEIRO, R.M., CAMPOS, M.M. & CALIXTO, J.B. (2001). Analysis of the mechanisms involved in the inflammatory response induced by des-Arg9-bradykinin in the rat pleural cavity. Inflamm. Res., 50, 570-576.
37. RICHARDSON, R.M., HARIBABU, B., ALI, H. & SNYDERMAN, R. (1996). Cross-desensitization among receptors for platelet-activating factor and peptide chemoattractants: evidence for independent regulatory pathways. J. Biol. Chem., 271, 28717-28724.
38. 1-receptor in cultured human lung fibroblasts. J. Clin. Invest., 101, 2080-2091.
39. SHARMA, J.N. & BUCHANAN, W.W. (1994). Pathogenic responses of bradykinin system in chronic inflammatory rheumatoid disease. Exp. Toxicol. Pathol., 46, 421-433.
40. SOARES, A.C, PINHO, V.S., SOUZA, D.G., SHIMIZU, T., ISHII, S., NICOLI, J.R. & TEIXEIRA, M.M. (2002). Role of the platelet-activating factor (PAF) receptor during pulmonary infection with gram negative bacteria. Br. J. Pharmacol., 137, 621-628.
41. 4 receptor antagonist inhibitis local and remote reperfusion injury after transient ischemia of the superior mesenteric artery in the rat. Eur. J. Pharmacol., 403, 121-314.
42. TEIXEIRA, M.M. & HELLEWELL, P.G. (1997). The effect of the selectin binding polysaccharide fucoidin on eosinophil recruitment in vivo. Br. J. Pharmacol., 120, 1059-1066.
43. ZHOU, W., JAVORS, M.A. & OLSON, M.S. (1994). Impaired surface expression of PAF receptors on human neutrophils is dependent upon cell activation. Arch. Biochem. Biophys., 308, 439-445.
44. ZIMMERMANN, M. (1983). Ethical guidelines for investigations of experimental pain in conscious animals. Pain, 6, 109.